Month: June 2019

EY announces winners of the Entrepreneur Of The Year® 2019 Greater Los Angeles Awards

Posted on June 21, 2019 by - Client News

Ernst & Young LLP (EY) is pleased to announce the winners of the Entrepreneur Of The Year® Awards in Greater Los Angeles. As the world’s most prestigious business awards program for entrepreneurs, Entrepreneur Of The Year recognizes business leaders who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities.

This group of entrepreneurial leaders was selected by an independent judging panel made up of previous award winners, leading CEOs, investors and other regional business leaders. The winners were unveiled at a black-tie gala on June 20, at The Beverly Hilton in Beverly Hills hosted by Christine Devine, KTTV Fox 11 News anchor.

“These inspiring entrepreneurs represent the leadership and brilliant ideas that drive growth and innovation in Greater LA,” said Scott Porter, Co-Director, Entrepreneur Of The Year in Greater Los Angeles. “It has been especially exciting to witness L.A.’s burgeoning entrepreneurial scene over the years. We’re delighted to celebrate these incredible innovators who have done so much for our community and our economy, and we’re grateful to be a part of their journey.”

The Entrepreneur Of The Year 2019 Greater Los Angeles Award winners are:

  • Emerging Business Software | Daniel Kim, Co-Founder and Co-CEO and Jay Lee, Co-Founder and Co-CEO | AuditBoard, Inc. | Cerritos, CA
  • Emerging Media | Guy Oranim, Co-Founder and CEO and Sharon Rechter, Co-Founder and President | First Media | Los Angeles, CA
  • Retail and Consumer Products | Daniel Broukhim, Co-Founder and Co-CEO, Michael Broukhim, Co- Founder and Co-CEO and Katie Kitchens, Co-Founder and Editor-in-Chief | FabFitFun | Los Angeles, CA
  • Transformational Leader | Jessica Hawthorne-Castro, Chairman and CEO | Hawthorne Direct, LLC | Los Angeles, CA
  • Advanced Technology | Ryan Hudson, Co-Founder and George Ruan, Co-Founder and CEO | Honey | Los Angeles, CA
  • Health and Wellness | Nate Snyder, Co-Founder and CEO | Ovation Fertility | Encino, CA
  • Consumer Technology and Services | Josh Meyers, CEO | Slickdeals, LLC | Hollywood, CA

Read the full announcement here.

CURE Pharmaceutical partners with Canada’s Canopy Growth

Posted on June 19, 2019 by - Client News

CURE Pharmaceutical Holding Corp has entered into a partnership with Canadian cannabis giant Canopy Growth Corp to develop a CBD product together.

The companies will be working on a low-dose CBD oral thin film that will use CURE Pharmaceutical’s patented CUREfilm technology. Canopy Growth will license the technology for global distribution.

CUREfilm will offer Canopy Growth a dosage that is “ideal for administering cannabinoids,” CURE said in a statement.

Read full coverage:

Canopy Growth, CURE Pharmaceutical To Work Together On CBD Oral Thin Films (Benzinga)
CURE Pharmaceutical, Canopy Growth to make CBD oral thin films (Seeking Alpha)

OC teen graduates high school thanks to Impella

Posted on June 17, 2019 by - Client News

On Nov. 11, 2016, his life took a startling turn by almost coming to an abrupt end. While lifting weights in the garage of his Huntington Beach home, Deits collapsed on the floor.

His “arrhythmogenic right ventricular cardiomyopathy,” in which fat and fibrous tissue replace muscle, caught all concerned unawares. “Usually, the first symptom of ARVC is cardiac arrest,” Deits noted.

Fortunately, his parents discovered him within minutes. Ted Deits preformed CPR on his son until the Huntington Beach Fire Department arrived. Paramedics defibrillated Deits’ heart twice without success. “I vividly remember thinking, ‘A family just lost a son today,’” recalled Capt. Travis Ponder. But after trying again in the ambulance, they detected a faint heartbeat.

Then came the real lifesaver: a newly approved heart pump for right-sided arrhythmia, which is relatively rare. More patients experience trouble with the heart’s left side. Hoag Hospital in Newport Beach had acquired the device, called an Impella, just one month before. Deits became the first child in the United States to undergo the procedure.

A few days later, the teen awoke from an induced coma with his sense of humor fully intact – alleviating concerns of brain damage due to loss of oxygen during the episode. Doctors implanted a pacemaker to regulate his heart rhythm.

Read the full article: Graduation 2019: 2 years after near-death heart attack, teen tolerates cap and gown — but he’d rather be skydiving (The Orange County Register)

Cloudbreak Health wins Best Overall MedTech Software at the 2019 MedTech Breakthrough Awards

Posted on June 6, 2019 by - Client News

Cloudbreak Health was just awarded the “Best Overall MedTech Software” award at the 2019 MedTech Breakthrough Awards. The program showcases technologies and companies that drive innovation and exemplify the best in medical and health related technology solutions across the globe.

Cloudbreak streamlines telemedicine and language services into the first unified telehealth platform in the country which supports multiple specialists on a single call. Cloudbreak Health offers a simple, flexible and cost-effective platform for hospitals and health providers to access a full suite of private-label interoperable telehealth solutions on iOS, PC and Android devices.

James Johnson, managing director of MedTech Breakthrough, said that “this year’s award winners showcase the impressive progress and positive momentum these new disruptive digital innovations are driving within the larger healthcare market. We are thrilled to announce our 2019 winners circle and we congratulate all of our MedTech Breakthrough Award winners.”

Read the full announcement: 2019 MedTech Breakthrough Awards Recognize “Breakthrough” Digital Health and Medical Technology Products and Companies

CURE Pharmaceutical featured on Strategic Investor Radio

Posted on June 5, 2019 by - Client News

Listen to Rob Davidson, CEO of CURE Pharmaceutical and corporate board member for several companies in the industry, discuss this niche in the pharma world.

“A publicly traded company, focusing on the delivery system of medications, with systems offering less toxicology and fewer side effects. With a proprietary system, they offer a delivery system that is unique and is not processed through the stomach.”

Hear the full podcast below.

 

Geneva Health Solutions featured at 40th Annual Heart Rhythm Society Scientific Session

Posted on June 5, 2019 by - Client News

Geneva Health Solutions, a solutions provider of technology-enabled services in the implantable cardiac device space and a BioTelemetry, Inc. company, released cardiac device data findings at the 40th Annual (2019) Heart Rhythm Society (HRS) conference. 

The moderated session titled, “The Role of Novel Remote Monitoring Data Management System Ameliorating Data Deluge from Implantable Loop Recorders,” was presented by Manish Wadhwa, M.D. F.H.R.S. (Fellow of the Heart Rhythm Society), Geneva’s Co-founder and Chief Medical Officer.

Dr. Wadhwa reviewed the following highlights at the conference:

  • Over a three-month time period, over 22,000 ILR reports poured onto the Geneva platform from one cardiology practice.
  • Approximately eight percent of these reports required immediate action, while seventy-eight percent of the reports did not contain useful information or represented data that could be stratified for timely but non-urgent review and reporting.
  • The Geneva platform was designed to collate these reports and provide practitioners more meaningful reporting.

Read full coverage:
Geneva Health Solutions, a BioTelemetry company, Featured at Heart Rhythm Society Scientific Session (CathLabDigest)
Geneva Health Solutions, a BioTelemetry company, Featured at Heart Rhythm Society Scientific Session (Invasive Cardiology)

 

REX spotlighted in Houston Chronicle

Posted on June 3, 2019 by - Client News

Houston local Kara Biggs recently bought a home with REX, which charges home sellers a 2 percent fee instead of the traditional 6 percent fee. REX can offer sellers that fee by declining to pay the buyer’s agent. Buyers have the option of having a salaried REX agent guide them through the transaction for free or paying for an outside agent themselves. Not making the buyer’s agent an offer also means that the listing cannot be advertised on multiple listing services, such as HAR.com and Realtor.com. REX’s homes can only be advertised directly to customers or on websites such as Zillow and Trulia, which only receive part of their listings from multiple listing services.

Jonathan Friedland, the company’s head of communications, said such restrictions are worth it in order to offer lower fees.

“If you’re in the (Multiple Listing Service) you’re bound to live within these rules. That’s what makes the MLS so problematic for anyone who is really trying to innovate in the industry,” he said. “If you don’t abide by some of these rules, you are kicked out.”

Read the full article: Class-action case could upend residential real estate brokerage business (Houston Chronicle)